X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Usual Pharma Compliance Issues Noted In FDA Warning Letters

    The FDA Has Finalized Its Prescription Drug REMS Guidelines

    Drug Inspection Pact Between Switzerland And United States

    Clinical Trials Regulation Implementation Progress Report

    Usual Pharma Compliance Issues Noted In FDA Warning Letters

    5 FDA Rulings To Keep An Eye On In The 2023 First Quarter

    Drugs To Watch For In 2023 That Could Become Blockbusters

    Gut Microbiota Is Important In Parkinsons, As Per A Study

    A Breakthrough Medication For Dystonia Is Being Developed

    Australia Introduces A New Tool To Lower Medicine Costs

    Dupixent Charts A Win Before The FDA Prurigo Nodularis Order

    Hong Kong University Creates Bone Anabolic Aptamer Drug

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Usual Pharma Compliance Issues Noted In FDA Warning Letters

    The FDA Has Finalized Its Prescription Drug REMS Guidelines

    Drug Inspection Pact Between Switzerland And United States

    Clinical Trials Regulation Implementation Progress Report

    Usual Pharma Compliance Issues Noted In FDA Warning Letters

    5 FDA Rulings To Keep An Eye On In The 2023 First Quarter

    Drugs To Watch For In 2023 That Could Become Blockbusters

    Gut Microbiota Is Important In Parkinsons, As Per A Study

    A Breakthrough Medication For Dystonia Is Being Developed

    Australia Introduces A New Tool To Lower Medicine Costs

    Dupixent Charts A Win Before The FDA Prurigo Nodularis Order

    Hong Kong University Creates Bone Anabolic Aptamer Drug

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development FDA Approvals

Drug Inspection Pact Between Switzerland And United States

Content Team by Content Team
17th January 2023
in FDA Approvals, News

The US and Switzerland have agreed to a Mutual Recognition Agreement (MRA) on pharmaceutical Good Manufacturing Practices (GMP).

The US Food and Drug Administration (FDA) and the Swiss Agency for Therapeutic Products (Swissmedic) will be able to utilize each other’s GMP audits of pharmaceutical manufacturing facilities under the terms of the agreement with the Swiss Confederation (Switzerland), eliminating the need for additional inspections.

Swiss-US Mutual Recognition Agreement (MRA)

Andi Lipstein Fristedt, the FDA’s Deputy Commissioner for Policy, Legislation, and International Affairs, who signed the contract on the agency’s behalf, explained that once the MRA goes into effect, the FDA will frequently be able to rely on the factual conclusions of Swissmedic experts, avoiding the need for additional inspections and enabling the FDA to extend its inspectional reach.

The agreement, according to Interpharma, the organisation for the pharmaceutical industry in Switzerland based on research, will boost the robustness of supply chains and hence enhance the safety of supply.

Standard Operating Procedures for Pharmaceutical Manufacturing

Good Manufacturing Practice (GMP) is the minimal requirement that a pharmaceutical manufacturer’s production procedures must meet, as stated by the European Medicines Agency (EMA). The FDA already has MRAs in place with the UK and the European Union (EU).

The FDA is now able to recognise medication inspections carried out by foreign regulatory bodies that have been found to be capable of carrying out inspections that comply with US standards according to the Food and Drug Administration Safety and Innovation Act, which was passed in 2012.

The US-Switzerland MRA has been subject to lengthy negotiations by the FDA’s Office of Global Policy and Strategy. Swissmedic must ascertain whether the FDA is qualified to carry out inspections that adhere to Swiss standards prior to the MRA going into effect. The FDA must decide whether Swissmedic complies with US regulations in a comparable manner.

The FDA’s Deputy Commissioner for Policy, Legislation, and International Affairs emphasized that MRAs provide a means for the FDA to function more effectively and optimize its capabilities in today’s global pharmaceutical industry.

Previous Post

Considerable Rise In Healthcare Deals Expected In 2023

Next Post

The FDA Has Finalized Its Prescription Drug REMS Guidelines

Related Posts

Usual Pharma Compliance Issues Noted In FDA Warning Letters
Drug Development

The FDA Has Finalized Its Prescription Drug REMS Guidelines

17th January 2023
Facilities & Operation

Considerable Rise In Healthcare Deals Expected In 2023

16th January 2023
IPR Data Management

A New Advancement In Disease Fighting Through Technology

13th January 2023
Clinical Trials

Clinical Trials Regulation Implementation Progress Report

13th January 2023
IPR Data Management

5 Concerns About Future of Developing Biotechnology In 2023

13th January 2023
Usual Pharma Compliance Issues Noted In FDA Warning Letters
FDA Approvals

5 FDA Rulings To Keep An Eye On In The 2023 First Quarter

13th January 2023
Next Post
Usual Pharma Compliance Issues Noted In FDA Warning Letters

The FDA Has Finalized Its Prescription Drug REMS Guidelines

Latest News

Usual Pharma Compliance Issues Noted In FDA Warning Letters
Drug Development

The FDA Has Finalized Its Prescription Drug REMS Guidelines

17th January 2023
FDA Approvals

Drug Inspection Pact Between Switzerland And United States

17th January 2023
Facilities & Operation

Considerable Rise In Healthcare Deals Expected In 2023

16th January 2023
IPR Data Management

A New Advancement In Disease Fighting Through Technology

13th January 2023
Clinical Trials

Clinical Trials Regulation Implementation Progress Report

13th January 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In